Cancer-related ischemic stroke:mechanisms,biomarkers and advances in therapeutic strategies
WANG Yu-xin
XU Zhi-ru
Abstract：Cancer-associated ischemic stroke(CAIS)has attracted increasing attention as a new subtype of stroke.Cancer-related prothrombotic states and treatment-related vascular toxicity elevate the risk of ischemic stroke in cancer patients,thereby posing unique challenges to the treatment and prognosis of these patients.However,the underlying mechanism between cancer and ischemic stroke is still unclear,and there is currently no unified diagnostic guideline,treatment,and prevention strategies.Therefore,this review comprehensively outlines the current research progress on the pathogenesis and biomarkers of CAIS,and explores personalized prevention and treatment strategies.
Keywords：hypercoagulabilitybiomarkerindividualized medicinecancerischemic stroke
Publication Date：2025-06-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 1199-1204 )